COVID-19: Beware of falsified medicines from unregistered websites
Recommendation

Tuesday, 29 September 2026 14.00 - 16.00 h
GDP-compliant Transport Processes: from Risk Assessment to Practical Implementation
The European Medicines Agency (EMA) is urging the general public not to buy medicines from unauthorized websites and other vendors aiming to exploit fears and concerns during the ongoing pandemic.
In a press release dated 24 March 2020, EMA states that "vendors may claim that their products can treat or prevent COVID-19 or may appear to provide easy access to legitimate medicines that are otherwise not readily available." EMA warns that such products are likely to be falsified medicines.
How to protect yourself from fraudulent vendors
To protect from fraudulent sellers, the EMA gives the following recommendations and advice:
- Patients should buy medicines only from a local pharmacy or retailer or from an online pharmacy that is registered with the national competent authorities.
- All registered online pharmacies have a common logo. Before buying, patients should check that the online pharmacy has this logo.
- Customers should click on the logo and will then be taken to the website of the national authority, and can check that the online pharmacy is listed on the national authority website.
- If the online pharmacy is not listed on the national authority website, one should not order there.
- In general, customers should never buy medicines advertised as cures or preventive treatments for COVID-19.
Related GMP News
10.09.2026European GDP Association Developments May through August 2026
10.09.2026Reminder: Submit your Presentation Proposal for the GDP Forum 2027 by 30 September
10.09.2026GDP in the US: FDA Launches DSCSA Assessment for Small Dispensers and Issues Exemptions
11.08.2026GDP for APIs: APIC Publishes Updated "How to Do" Document
11.08.2026Where to Find Information on UK Wholesale Authorisations


